Blood cancer treatment varies dramatically by subtype—acute myeloid leukemia, chronic lymphocytic leukemia, Hodgkin lymphoma, and multiple myeloma each demand distinct therapeutic approaches. Not every hospital tailors protocols to these differences. Key Takeaways Personalized blood cancer treatment requires subtype-specific protocols matched to AML, ALL, CML, lymphoma, or myeloma using advanced diagnostics like immunophenotyping and genetic profiling Hospitals with multidisc